These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38966846)

  • 1. Breast Cancer in a Filipino Male: A Case Report and Brief Literature Review.
    Zaldarriaga JMH; Aw AMN; Vega GP; Gaerlan-Tagle A; Pena-Camacho A; Magsanoc JMJ
    Acta Med Philipp; 2024; 58(3):70-75. PubMed ID: 38966846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma of the Breast Presenting as Occult Breast Cancer With Axillary and Supraclavicular Lymph Node Metastasis: A Case Report.
    Aleman Espino A; Bernal IC; Guarecuco JE; El-Tawil R; Masri MM
    Cureus; 2023 May; 15(5):e39583. PubMed ID: 37384084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant Chemotherapy.
    Flores-Balcázar CH; Castro-Alonso FJ; Hernández-Barragán TP; Delgado-de la Mora J; Daidone A; Trejo-Durán GE
    Oncology (Williston Park); 2021 Mar; 35(3):139-143. PubMed ID: 33818049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction.
    Kubota Y; Han Q; Masaki N; Hozumi C; Hamada K; Aoki Y; Obara K; Tsunoda T; Hoffman RM
    Anticancer Res; 2022 Dec; 42(12):5819-5823. PubMed ID: 36456116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.
    Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M
    Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
    Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
    Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case Performed Mastectomy to Tumor Progression of Breast Cancer Omitting Surgery after Neoadjuvant Chemotherapy].
    Hojo S; Yoshioka S; Wakabayashi Y
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1594-1596. PubMed ID: 36733146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer.
    Brady EW
    Breast J; 2002; 8(2):97-100. PubMed ID: 11896755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.
    Singh JC; Mamtani A; Barrio A; Morrow M; Sugarman S; Jones LW; Yu AF; Argolo D; Smyth LM; Modi S; Schweber S; Boafo C; Patil S; Norton L; Baselga J; Hudis CA; Dang C
    Oncologist; 2017 Feb; 22(2):139-143. PubMed ID: 28167568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Reconstruction With Postmastectomy Radiation: Choices and Tradeoffs.
    Poppe MM; Agarwal JP
    J Clin Oncol; 2017 Aug; 35(22):2467-2470. PubMed ID: 28481705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of a patient with inflammatory breast cancer who responded to preoperative chemotherapy with paclitaxel plus bevacizumab and could subsequently undergo surgery].
    Kashiwagi S; Ishihara S; Ishii M; Asano Y; Watanabe M; Morisaki T; Aomatsu N; Noda S; Kawajiri H; Nakano T; Kawakami N; Mitsukawa Y; Takashima T; Onoda N; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2384-6. PubMed ID: 24394120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.
    Kuerer HM; Newman LA; Buzdar AU; Hunt KK; Dhingra K; Buchholz TA; Binkley SM; Ames FC; Feig BW; Ross MI; Hortobagyi GN; Singletary SE
    Am J Surg; 1998 Dec; 176(6):502-9. PubMed ID: 9926779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy.
    Bonev V; Evangelista M; Chen JH; Su MY; Lane K; Mehta R; Butler J; Hsiang D
    Am Surg; 2014 Oct; 80(10):940-3. PubMed ID: 25264634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
    Loibl S; O'Shaughnessy J; Untch M; Sikov WM; Rugo HS; McKee MD; Huober J; Golshan M; von Minckwitz G; Maag D; Sullivan D; Wolmark N; McIntyre K; Ponce Lorenzo JJ; Metzger Filho O; Rastogi P; Symmans WF; Liu X; Geyer CE
    Lancet Oncol; 2018 Apr; 19(4):497-509. PubMed ID: 29501363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Metaplastic Squamous Cell Carcinoma of the Breast that Showed a Pathological Complete Response After Neoadjuvant Chemotherapy with Weekly Paclitaxel.
    Noro A; Ishitobi M; Hanamura N; Kashikura Y; Yamashita M; Kozuka Y; Saito K; Mizuno T; Ogawa T
    Am J Case Rep; 2022 Jan; 23():e935035. PubMed ID: 35017459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metaplastic breast cancer with a unique presentation and complete response to chemotherapy: a case report.
    Nahhat F; Doyya M; Zabad K; Ksiri H
    BMC Womens Health; 2024 May; 24(1):285. PubMed ID: 38734591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.